• No results found

Drug candidates in clinical trials for Alzheimer’s disease

N/A
N/A
Protected

Academic year: 2020

Share "Drug candidates in clinical trials for Alzheimer’s disease"

Copied!
12
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

Fig. 1 Classification of therapeutic drugs or targets in the treatmentof Alzheimer’s disease according to neuropathological hallmarks

References

Related documents

In the presented model, after determining the inventory cost functions regarding obsolescence, holding and delay in payment costs, which are related to the

The current study was carried out to (i) evaluate the soil quality depending on soil physical and chemical characteristics as well as biodiversity factors; (ii) assess the effects

Estimates of 2015 impervious cover (IC) for the 52 towns of the Piscataqua Region Estuaries Partnership (PREP) were generated from 2015 1-foot imagery (for the 42 towns in NH) and

Splátky v době čerpání meziúvěru jsou součtem částky na spoření (915 Kč) a splátky úroků meziúvěru, při úrokové sazbě 5,1 % p.. Jak jsem jiţ uvedla dříve, výši částek si

Financial regulators: require companies to disclose the potential emissions of CO 2 embedded in fossil fuel reserves; incorporate climate change risk into the assessment

Abbreviations: RBs, restrictive bare stent; sine, stent graft-induced new entry; TBaD, type B aortic dissection; TeVaR, thoracic endovascular aortic repair.. Therapeutics and

Auto- fluorescence can be enhanced by the addition of ex- ogenous chromophores, such as photosensitisers, fa- cilitating the monitoring of drug localisation proper-